CytoSorbents Corporation announced that its CEO Dr. Phillip Chan and CFO Mr. Peter Mariani will attend the Jefferies Global Healthcare Conference in London from November 16-18, 2026. This event gathers healthcare industry leaders and investors to discuss advancements and investment opportunities. CytoSorbents specializes in blood purification technologies used in critical care and cardiac surgery, with products approved in the EU and under development in the US and Canada. The meetings aim to engage investors and provide updates on the company's regulatory progress and product pipeline.
CytoSorbents Corporation's upcoming participation at the 2026 Jefferies Global Healthcare Conference in London provides context for healthcare sector activity. For readers following healthcare stocks, here is Pluang's market snapshot as of Nov 09, 2026 18:41 WIB: out of 150 priced US health-sector stocks tradable on Pluang, 108 rose and 26 fell today. Notable gainers include TG Therapeutics Inc (TGTX) at USD 63.00 with a 1-day change of +5.31%, Guardant Health Inc. (GH) at USD 157.76 up +4.57%, and ClearPoint Neuro Inc (CLPT) at USD 8.99 up +4.53%.
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...
ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...
Credit Agricole Toulouse 31 disclosed its weekly transactions involving the buyback of its cooperative investment certificates (CCI) from November 2 to November 6, 2026. The bank repurchased varying volumes daily, with prices ranging around 98.82 to ...
